Tozinameran/famtozinameran

N/A

Report date: 2026/02/02 16:27:08

Base Information

Drug NameTozinameran/famtozinameran
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulantsCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date2022/10/11
Country/TerritoryCanadaUnited KingdomSouth Korea
CombinationsYes Tozinameran
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBioNTech Manufacturing GmbH
China Registration ClassN/A

Develop Information

Active CompaniesBioNTech Manufacturing GmbH
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A